سعر هيموكابرون 500مجم 20 قرص 2022

Tranexamic acid 500 mg film-coated tablets, pack of 20 (Hemokapron, EGPI > Sonesta Pharmaceuticals Co), an oral antifibrinolytic.

• Haemorrhage or risk of haemorrhage in increased fibrinolysis (prostatectomy/bladder surgery, menorrhagia, epistaxis, cervical conisation, traumatic hyphaema)Population: Adultselectronic medicines compendium (emc), UK
• Hereditary angioneurotic oedemaelectronic medicines compendium (emc), UK
• Management of dental extraction in haemophiliacsPopulation: Patients with haemophiliaelectronic medicines compendium (emc), UK

• Very rare hypersensitivity including anaphylaxis; rare colour vision disturbances, retinal/artery occlusion, thromboembolic events and allergic skin reactions; very rare nausea, vomiting, diarrhoea (dose-related); not known: fixed drug eruption, convulsions (particularly with misuse), acute renal cortical necrosis.International label, equivalent formulation · electronic medicines compendium (emc), UK

• Severe renal impairment (risk of accumulation); hypersensitivity; active thromboembolic disease; history of venous or arterial thrombosis; fibrinolytic conditions following consumption coagulopathy; history of convulsions.International label, equivalent formulation · electronic medicines compendium (emc), UK

• Haematuria of renal origin: risk of urinary obstruction - monitor closely. Long-term use in hereditary angioedema: regular eye examinations and liver function tests. Irregular menstrual bleeding should be investigated before use. Use with care with oral contraceptives (thrombosis risk) and in patients with previous thromboembolism/thrombophilia. Not recommended in DIC. Withdraw if visual disturbance occurs. Convulsions have been reported (mostly with high IV doses).International label, equivalent formulation · electronic medicines compendium (emc), UK

• Fibrinolytic (thrombolytic) preparationsTranexamic acid counteracts the thrombolytic effect of fibrinolytic preparations.electronic medicines compendium (emc), UK
• Oral (hormonal) contraceptivesIncreased risk of thrombosis; administer with care.electronic medicines compendium (emc), UK

• No evidence of teratogenic effect in animal studies, but the usual caution with drugs in pregnancy should be observed; tranexamic acid crosses the placenta.International label, equivalent formulation · electronic medicines compendium (emc), UK
• Passes into breast milk at about one hundredth of the maternal blood concentration; an antifibrinolytic effect in the infant is unlikely.International label, equivalent formulation · electronic medicines compendium (emc), UK

• Tranexamic acid: Forms a complex with plasminogen and inhibits the fibrinolytic properties of plasmin, exerting an antihaemorrhagic effect.